Skip to main content
Veterinary Medicines

Metrovis 250 mg tablets for dogs and cats

Authorised
  • Metronidazole

Product identification

Medicine name:
Metrovis 250 mg tablets for dogs and cats
Metrovis
Active substance:
  • Metronidazole
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Metronidazole
    250.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XD01
  • QP51AA01
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:
  • 5 Aluminium - PVC-PE-PVDC blisters of 10 tablets in a cardboard box.
  • 25 Aluminium - PVC-PE-PVDC blisters of 10 tablets in a cardboard box.
  • 2 Aluminium - PVC-PE-PVDC blisters of 10 tablets in a cardboard box.
  • 10 Aluminium - PVC-PE-PVDC blisters of 10 tablets in a cardboard box.
  • 1 Aluminium - PVC-PE-PVDC blister of 10 tablets in a cardboard box.
  • 50 Aluminium - PVC-PE-PVDC blisters of 10 tablets in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Livisto Int'l S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
  • aniMedica Herstellungs GmbH
  • Industrial Veterinaria S.A.
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 36077
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0249/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 15/11/2023
Download

Final PuAR Metrovis 100 mg 250 mg 750 mg_08102023.pdf

English (PDF)
Published on: 25/10/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."